
Marshall Stoller
Chief of Endourology · University of California (San Francisco) School of Medicine
Credentials: · · ·
History
- Present
Endourology Division · University of California (San Francisco) School of Medicine
- Present
Urology · Henry Ford Health
- 1977–1981
- 1972–1976
University of California, Berkeley, CA, Bioenergetics
Research
Ultrasonography versus computed tomography for suspected nephrolithiasis
New England Journal of Medicine · 2014 · 444 citations
Estimated blood loss and transfusion rates associated with percutaneous nephrolithotomy
The Journal of Urology · 1994 · First of 3 authors · 170 citations
Review · Urologic Clinics of North America · 2000 · 165 citations

101 papers · 27 as a resident

47 papers · 37 as a fellow

25 papers · 21 as a resident

23 papers · 23 as a fellow

21 papers · 17 as a resident

21 papers · 21 as a fellow

20 papers

20 papers · 17 as a fellow
Grants
- 2023–2028
Learners to LeAders in Benign Urology, Benign Nephrology, and Non-Cancer Hematology
National Institute of Diabetes and Digestive and Kidney Diseases · U2C
PI · $3.2M · University of California, San Francisco
- 2025–2027
National Institute of Diabetes and Digestive and Kidney Diseases · R21
Contact PI · $423K · University of California, San Francisco
- 2017–2024
Phase 2: Impact of Lipoic Acid on Cystine Nephrolithiasis; IND129545 (01/29/2016)
Food and Drug Administration · R01
Contact PI · $2.1M · University of California, San Francisco
- 2016–2019
Multiscale Form and Function Can Predict Renal Biomineralization
National Institute of Diabetes and Digestive and Kidney Diseases · R21
PI · $435K · University of California, San Francisco
Clinical trials
- 2024–2026
Methylglyoxal (MGO) Lowering Cocktail to Reduce Appetite in Obese Individuals
Principal investigator · Withdrawn · Phase 1, Phase 2
University of California, San Francisco
- 2023–2025
Long Term Clinical Efficacy of Sodium-glucose Cotransporter-2 (SGLT-2) Inhibitor in Cystinurics
Principal investigator · Withdrawn · Phase 2
University of California, San Francisco
- 2021–2022
Principal investigator · Completed · Phase 2
University of California, San Francisco

